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Sympathetic neurons depend on target-derived neu-
rotrophic cues to control their survival and growth.
However, whether sympathetic innervation contrib-
utes reciprocally to the development of target tissues
is less clear. Here, we report that sympathetic inner-
vation is necessary for the formation of the pancre-
atic islets of Langerhans and for their functional
maturation. Genetic or pharmacological ablation of
sympathetic innervation during development re-
sulted in altered islet architecture, reduced insulin
secretion, and impaired glucose tolerance in mice.
Similar defects were observed with pharmacological
blockade of b-adrenergic signaling. Conversely, the
administration of a b-adrenergic agonist restored
islet morphology and glucose tolerance in deinner-
vated animals. Furthermore, in neuron-islet cocul-
tures, sympathetic neurons promoted islet cell
migration in a b-adrenergic-dependent manner.
This study reveals that islet architecture requires
extrinsic inductive cues from neighboring tissues
such as sympathetic nerves and suggests that early
perturbations in sympathetic innervation might un-
derlie metabolic disorders.INTRODUCTION
The sympathetic nervous system, a branch of the autonomic
nervous system, is critical for organ homeostasis. Postgangli-
onic sympathetic neurons innervate a variety of peripheral tar-
gets to regulate several physiological processes, including blood
glucose levels, cardiac output, and body temperature. During
development, the survival and growth of sympathetic neurons
rely on diffusible cues released by their targets (Glebova and
Ginty, 2005). However, whether sympathetic innervation contrib-
utes reciprocally to themorphogenesis of a target tissue remains
unknown. The pancreas is a peripheral tissue that is richly inner-vated by adrenergic sympathetic nerves originating from the
celiac and superior mesenteric ganglia (Woods and Porte,
1974). The islets of Langerhans in the endocrine pancreas regu-
late blood glucose homeostasis, and islet dysfunction underlies
diabetes mellitus. In adult islets, sympathetic neural activity is
well known to inhibit insulin secretion and promote glucagon
release to elicit an increase in circulating glucose during stress
and exercise (Ahre´n, 2000; Woods and Porte, 1974). Develop-
mentally, sympathetic innervation of the pancreas is promoted
by the target-derived neurotrophin, nerve growth factor, NGF.
Sympathetic innervation of the pancreas is incomplete in mice
lacking NGF (Glebova and Ginty, 2004), whereas directed over-
expression of NGF in b cells results in hyperinnervation of the
pancreatic islets (Edwards et al., 1989). The onset of sympa-
thetic innervation is coincident with stages of rapid growth, dif-
ferentiation, and maturation in the embryonic pancreas (Burris
and Hebrok, 2007). Previous studies indicate that pancreatic
development is dependent on instructive signals derived from
neighboring tissues, including the mesenchyme and blood ves-
sels (Golosow and Grobstein, 1962; Lammert et al., 2001). There
is also growing evidence that dysfunction of the neuronal ele-
ments in the developing pancreas might be an instigating factor
in the pathogenesis of pancreatic diseases. An early loss of sym-
pathetic fibers and glial cells in the pancreas has been observed
in diabetic animal models (Mei et al., 2002; Persson-Sjo¨gren
et al., 2005; Winer et al., 2003). However, whether sympathetic
innervation contributes to pancreatic organogenesis remains
unknown.
Pancreatic islets are highly organized functional micro-organs
with defined size, shape, and a distinctive arrangement of endo-
crine cells. Islet architecture has been postulated to underlie
effective intercellular coupling, synchronized insulin release,
and paracrine regulation by the islet microvasculature (Bonner-
Weir, 1988; Halban, 2004; Santos et al., 1991; Stagner and
Samols, 1986; Valdeolmillos et al., 1989). Although interspecies
differences in islet organization have been reported (Cabrera
et al., 2006; Wieczorek et al., 1998), significant evidence sug-
gests a unifying model that islet architecture, which optimizes
cell-cell interactions between b cells, is essential in the acquisi-
tion of an adult pattern of insulin secretion (Halban et al., 1982;
Konstantinova et al., 2007; Ravier et al., 2005; Yamagata et al.,Cell Reports 4, 287–301, July 25, 2013 ª2013 The Authors 287
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Figure 1. Sympathetic Innervation Establishes Islet Architecture and the Spatial Distribution of Endocrine Cells
(A–C) TH immunohistochemistry and GFP fluorescence reveal the organization of b cells into discrete clusters near sympathetic fibers during development in
MIP-GFP mice.
(D and E) Chemical sympathectomy with 6-OHDA administration disrupts islet clustering in neonatal MIP-GFP mice. GFP+ b cells (green) and DAPI (nuclei)
staining are shown.
(F) Genetic ablation of sympathetic innervation in TH-Cre;TrkAf/f mice. Immunoblotting shows depleted TrkA protein levels in SCGs from TH-Cre;TrkAf/f mice at
P2, and intact TrkA expression in islets. The p85 subunit of phosphatidylinositol 3-kinase (PI3K) was used to normalize for protein amounts.
(G and H) Immunohistochemistry for TH and insulin shows that sympathetic axons (arrows) surrounding control TrkAf/f islets (G) are lost in TH-Cre;TrkAf/f islets
(H) by P6.
(legend continued on next page)
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2002). Perturbed islet organization is also a characteristic feature
in diabetic humans and in animal models of the disease (Gepts
and Lecompte, 1981; Go´mez Dumm et al., 1990; Kilimnik
et al., 2011; Tokuyama et al., 1995). In murinemodels, islet archi-
tecture has been shown to be established during late embryonic
to early neonatal stages through a sequence of morphogenetic
events, including delamination of endocrine precursors from a
primordial ductal epithelium, endocrine cell migration into the
surrounding mesenchyme, and clustering to form nascent islets
(Puri and Hebrok, 2010). Although a cascade of transcription
factors has been identified in the regulation of pancreatic cell
specification and growth, relatively little is known about the sig-
nals responsible for the coordination of endocrine cell migration
and establishment of islet organization.
By employing genetic and chemical ablation of sympathetic
neurons in mice, we show that sympathetic innervation is neces-
sary for establishing pancreatic islet shape and cytoarchitecture
during development. Sympathectomized mice exhibit impaired
glucose tolerance due to defects in glucose-stimulated insulin
secretion (GSIS) later in life. Using neuron-islet cocultures, we
show that sympathetic neurons promote the directed migration
of b cells. We identify the nerve-derived signal as norepinephrine
acting via pancreatic b-adrenergic receptors to influence islet
cell migratory behavior. The effects of sympathetic deinnervation
on islet architecture and glucose tolerance are recapitulated
by the developmental blockade of b-adrenergic signaling.
Remarkably, the pharmacological stimulation of b-adrenergic
signaling during development is sufficient to restore islet mor-
phologies and glucose metabolism in sympathectomized mice.
Together, our results indicate that sympathetic neurons use
noradrenergic signaling to establish the architecture of pancre-
atic islets and that this inductive interaction at early stages of
development is critical for mature islet function in regulating
glucose metabolism.
RESULTS
Sympathetic Innervation Is Necessary for Establishing
Islet Architecture
To address the role of sympathetic innervation in pancreatic islet
development, we visualized sympathetic nerves in the devel-
oping pancreas using immunofluorescent staining for tyrosine
hydroxylase (TH), a sympathetic nerve marker, on tissue sec-
tions from MIP-GFP transgenic mice, which express GFP re-
porter under the insulin promoter (Hara et al., 2003). We found
that sympathetic fibers innervate the developing pancreas as
early as embryonic day 14.5 (E14.5), when GFP-labeled b cells
are scattered throughout the pancreas (Figure 1A). At E18.5,(I and J) Immunostaining for islet hormones shows disrupted arrangement of end
(K) Islet shape is quantified by circularity index.
(L) Percentage of islets with mis-localized a cells.
(M) Normal endocrine cell numbers in P6 TH-Cre;TrkAf/f mutants.
(N and O) Intact islet vasculature in sympathectomized animals. The density a
(arrowheads) are not compromised, despite the alterations in islet architecture i
Alexa 633-conjugated wheat germ agglutinin (WGA) into TH-Cre;TrkAf/f and con
For all quantifications, n = 3 mice per genotype. Mean ± SEM. *p < 0.05, ***p < 0
See also Figure S1.more GFP-labeled b cells are found in the vicinity of TH-positive
sympathetic fibers, where they begin to form aggregates (Fig-
ure 1B). By the first postnatal week (P6), discrete islet clusters
are formed andwrapped by sympathetic fibers (Figure 1C). Strik-
ingly, ablation of sympathetic innervation in neonatal mice using
the neurotoxin, 6-hydroxydopamine (6-OHDA) (Kostrzewa and
Jacobowitz, 1974), resulted in a profound disorganization of
islets, with the islets appearing as large streak-like aggregates
instead of the characteristic globular clusters (Figures 1D and
1E). Daily administration of 6-OHDA in newborn mice resulted
in the complete loss of sympathetic innervation by P6 (Figures
S1A and S1B).
We further used a genetic approach to ablate sympathetic
innervation. The survival and target innervation of sympathetic
neurons depend on the expression of the TrkA receptor, which
mediates trophic effects of the neurotrophin, NGF, secreted by
target tissues (Glebova and Ginty, 2005). We crossed mice
harboring a conditional (floxed) TrkA allele (Chen et al., 2005)
with mice expressing TH-driven Cre recombinase (TH-Cre)
(Gong et al., 2007). In TH-Cre;TrkAf/f mutant mice, we observed
a selective depletion of TrkA protein in sympathetic neurons,
whereas the expression of TrkA in islets was unaffected (Fig-
ure 1F). Previous studies have reported that in rodents, TrkA is
localized to b cells in neonatal and adult islets (Kanaka-Ganten-
bein et al., 1995; Miralles et al., 1998). By the first week of birth
(P6), whereas an enrichment of TH-positive sympathetic fibers
was observed at the periphery of islets in control TrkAf/f animals
(Figure 1G, arrows) (Burris and Hebrok, 2007; Rodriguez-Diaz
et al., 2011), there was a complete loss of sympathetic innerva-
tion in the pancreas and several other peripheral tissues in
TH-Cre;TrkAf/f mutant mice (Figures 1H and S1C–S1H).
In neonatal mice, immunostaining with the islet hormone
markers, insulin and glucagon, revealed that wild-type islets
had coalesced into globular clusters with the stereotypical
arrangement of insulin-producing b cells at the core surrounded
by glucagon-producing a cells at the periphery or mantle (Fig-
ure 1I). In contrast, in TH-Cre;TrkAf/f mutants, significant disrup-
tions in islet cytoarchitecture were evident with islets appearing
as disorganized aggregates with an intermingling of a cells and b
cells within the islet core (Figures 1J–1L). The total number of a
and b cells remained unaffected (Figure 1M). Despite the pertur-
bation of islet organization in TH-Cre;TrkAf/f mice, the islets still
retained a dense meshwork of microvasculature, indicating
that ablation of innervation does not impair islet vasculariza-
tion (Figures 1N and 1O). Significant disruptions in islet cytoarch-
itecture with mixed a cells and b cells within the islet core, in
the absence of any significant changes in islet cell numbers,
were also observed in the neonatal 6-OHDA-injected miceocrine cells within islets in neonatal (P6) TH-Cre;TrkAf/f mice.
nd morphology of the pancreatic blood vessels (arrows) and islet capillaries
n TH-Cre;TrkAf/f pups. Blood vessels were fluorescently painted by perfusing
trol mice at P6.
.001, t test. Scale bars, 50 mm.
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Figure 2. Defects in Islet Cell-Cell Contacts and GSIS in Sympathectomized Mice
(A and B) Reduced N-CAM expression in islets from P21 TH-Cre;TrkAf/f mice.
(C and D) Higher-magnification images of regions from (A) and (B).
(E and F) Reduced expression of E-cadherin in islets from P21 TH-Cre;TrkAf/f animals compared to control mice.
(G and H) Higher-magnification images of regions in (E) and (F) show an uneven distribution of E-cadherin at junctions between adjacent b cells in mutant islets.
Mutant islets also exhibit abnormalities in cellular spacing and gaps devoid of any cells (arrowheads in B and F).
(I) Isolated islets from 1-month-old TH-Cre;TrkAf/f mice secrete less insulin when challenged with high glucose or with potassium chloride treatment. Insulin
released is expressed as a percentage of the total insulin content (n = 5 mice per genotype). t test.
(J) Total insulin content is normal in isolated islets from TH-Cre;TrkAf/f mice. Insulin content is normalized to total islet DNA content (n = 4 mice per genotype).
(legend continued on next page)
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(Figures S1I–S1M). These results suggest that sympathetic
innervation is necessary for the establishment of islet shape
and cytoarchitecture.
TH is also expressed in a subset of b cells in the wild-type
pancreas (Teitelman and Lee, 1987). Consistent with previous
reports by Teitelman and Lee (1987), we found 3% of insulin-
positive b cells showing TH immunoreactivity in wild-type islets
(Figure S1N, arrowheads, and Figure S1P). We noticed that there
was a large increase in the number of TH-expressing b cells in
TH-Cre;TrkAf/fmice (Figures S1O and S1P). Despite the increase
in TH expression in TH-Cre;TrkAf/f mutant islets, no changes in
TrkA levels were detected by immunoblotting (Figure 1F) or
quantitative PCR analysis (Figure S1Q), indicating that the islet
deficits observed in TH-Cre;TrkAf/f mice were not due to
changes in TrkA levels in the islets themselves. Interestingly,
the number of TH-positive b cells was unaffected by 6-OHDA
treatment (Figures S1R–S1T).
Sympathetic Innervation Is Required for Islet Cell-Cell
Contacts and Glucose-Stimulated Insulin Secretion
Given that perturbations in cytoarchitecture are associated with
alterations in cell-cell interactions within islets (Jain and Lam-
mert, 2009), we analyzed the expression of the major islet cell
adhesion molecules: neural cell adhesion molecule (N-CAM)
and E-cadherin (Dahl et al., 1996; Esni et al., 1999). In postnatal
TH-Cre;TrkAf/f islets, we observed an overall reduction in N-CAM
expression in b cells (Figures 2A and 2B), with little immunoreac-
tivity detected at the junctions between adjacent b cells (Figures
2C and 2D). Immunostaining analyses also revealed a downre-
gulation in E-cadherin levels in mutant b cells (Figures 2E and
2F). In mutant b cells that still showed E-cadherin immunoreac-
tivity, there were noticeable changes in its subcellular distribu-
tion. Although wild-type b cells showed a continuous distribution
of E-cadherin at the sites of b cell-cell contacts (Figure 2G), we
observed a ‘‘patchy’’ uneven pattern of E-cadherin labeling
between neighboring b cells in mutant islets (Figure 2H). These
analyses also revealed irregularly spaced clusters of b cells in
mutant islets, with ‘‘lesions’’ that were devoid of any cells (arrow-
heads in Figures 2B and 2F), compared to control islets where b
cells were closely packed (Figures 2A and 2E). Together, these
results indicate that the loss of sympathetic innervation results
in abnormalities in cell-cell contacts and cellular spacing of b
cells in TH-Cre;TrkAf/f islets.
Isletmorphology andcytoarchitecture havebeenpostulated to
be determinants in the acquisition of functional maturity (Bosco
et al., 1989; Halban et al., 1982; Hopcroft et al., 1985; Ravier
et al., 2005). We thus assessed GSIS in TH-Cre;TrkAf/f mice
and wild-type littermates at 1 month of age, when islets have ac-
quired functional maturity (Jermendy et al., 2011). Mutant islets
exhibited significant reduction in GSIS (Figure 2I), although they(K–N) Reduced expression and surface localization of the glucose transporter, Glu
mice per genotype).
(O–Q) Ultrastructural analysis of b cells reveals fewer insulin granules within 50
represent insulin granules docked per mm of the plasma membrane (n = 3 mice
(R) The total number of insulin granules (per mm2) is not different between mutan
Mean ± SEM. *p < 0.05, **p < 0.01, t test. Scale bars, 50 mm (A, B, E, F, M, and
See also Figure S2.had normal insulin content (Figure 2J). The attenuated response
of deinnervated islets to a glucose challenge suggests that sym-
pathetic innervation during development is necessary for func-
tional maturation of the islets. To address the mechanisms
underlying deficientGSIS in deinnervated islets, we assessed as-
pects of glucose sensing and insulin trafficking. The b cell-spe-
cific glucose transporter, Glut2, is essential for glucose entry
into b cells and activation of the glycolytic pathway that subse-
quently fuels insulin secretion (Thorens, 2003). Glut2 deletion
leads to severe defects in insulin secretion in mice (Guillam
et al., 1997). Although it is reported that Glut2 is not the predom-
inantly expressed glucose transporter in human b cells (De Vos
et al., 1995), new evidence points to recessive mutations in
Glut2 in patients with neonatal diabetes (Sansbury et al., 2012;
Yoo et al., 2002). TH-Cre;TrkAf/f islets exhibited reduced protein
expression and surface localization of Glut2 at 1 month of age
(Figures 2K–2N), and these deficits were evident as early as P6
(Figures S2A–S2D). Themutant islets also failed to secrete insulin
in response to potassium chloride-mediated depolarization (Fig-
ure 2I), suggesting defects in the mobilization of a readily releas-
able pool of insulin (Seino et al., 2011). Ultrastructural analyses
revealed fewer insulin granules at or very close (within 50 nm)
to the plasma membrane in TH-Cre;TrkAf/f islets compared to
control TrkAf/f islets (Figures 2O–2Q). The total number of insulin
granules was not significantly different between control and
mutant b cells (Figure 2R), consistent with the finding in Figure 2J.
Together, these results indicate that the failure of mutant islets to
respond to glucose arises from impaired glucose sensing and a
reduction in the number of docked insulin granules. We also
noticed that TH-Cre;TrkAf/f animals exhibited reductions in islet
size that were only manifested by 1 month of age (Figures 2N
and S2E–S2G). The decreased islet mass in mutant animals is
likely, at least in part, due to an overall reduction in body weight
in mature TH-Cre;TrkAf/f animals (Figures S2H and S2I). The
exocrine, ductal, and vascular compartments in TH-Cre;TrkAf/f
pancreata all appeared normal (data not shown).
Sympathectomized Mice Are Glucose Intolerant
We then assessed metabolic parameters at the whole-animal
level in TH-Cre;TrkAf/f mice. At 1 month of age, TH-Cre;TrkAf/f
mice showed normal fasting blood glucose levels (Figure S3A)
but were hyperglycemic when fed ad libitum (Figure 3A). Further-
more, when TH-Cre;TrkAf/f mice were challenged in a glucose
tolerance test, they had significantly elevated blood glucose
levels as compared to control TrkAf/f mice (Figure 3B). Consis-
tent with reduced GSIS in isolated TH-Cre;TrkAf/f islets, plasma
insulin levels were severely attenuated in response to the
glucose challenge in TH-Cre;TrkAf/f mice (Figure 3C). However,
the TH-Cre;TrkAf/f mice responded normally with a significant
reduction in blood glucose levels when injected with insulint2, in mutant b cells as revealed by immunostaining and immunoblotting (n = 3
nm of the plasma membrane (arrowheads), in mutant islets. Numbers in (Q)
per genotype).
t and control islets (n = 3 mice per genotype).
N), 10 mm (C, D, G, and H), and 1 mm (O and P).
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Figure 3. Sympathectomized Mice Exhibit
Impaired Glucose Tolerance but Normal In-
sulin Sensitivity
(A) Elevated blood glucose levels in 1-month-old
TH-Cre;TrkAf/f compared to control mice when fed
ad libitum (n = 9 mice per genotype).
(B) Glucose intolerance in TH-Cre;TrkAf/f mice.
Mice, at 1 month of age, were fasted overnight,
then injected i.p. with a bolus of 2 g/kg glucose at
t = 0. Blood glucose measurements were made
from tail vein at the indicated time intervals after
glucose injection (n = 10 mice per genotype).
(C) Reduced plasma insulin levels in response to a
glucose injection (3 g/kg glucose) in TH-Cre;TrkAf/f
mice compared to control mice (n = 8 control, 10
mutant mice).
(D) Normal insulin sensitivity in TH-Cre;TrkAf/f
mice. A significant decrease (p < 0.001, t test) in
blood glucose levels was seen in both TH-Cre;
TrkAf/f and control mice at 30 min after insulin in-
jection compared to t = 0. Mice were treated with
0.75 U/kg of insulin, and blood glucose measure-
ments were made from tail blood at the indicated
times postinjection (n = 5 mice per genotype).
Mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001,
t test.
See also Figure S3.(Figure 3D), suggesting that the insulin sensitivity of muscle,
adipose, and liver tissues is not perturbed despite the loss of
sympathetic innervation. In addition, the plasma levels of other
pancreatic hormones, glucagon and ghrelin, as well as that of
several nonpancreatic hormones known to influence b cell
biology, i.e., the gut-derived incretins (GIP and GLP-1), other
gut-derived peptides (cholecystokinin, gastrin, and secretin) as
well as adipose-derived leptin were all normal in TH-Cre;TrkAfl/fl
mice (Figures S3B–S3I). Together, these findings indicate that
sympathetic innervation during development is necessary for
glucose homeostasis later in life and that the impaired glucose
tolerance in the mutants arises primarily from islet dysfunction
rather than broader physiological defects stemming from the
loss of sympathetic innervation.
Sympathetic Deinnervation in Mature Animals Does Not
Affect Islet Architecture and Glucose Tolerance
To determine whether sympathetic innervation is required during
later postnatal stages of the development for islet architecture
and glucose responsiveness, we ablated sympathetic innerva-
tion in young animals at P21 by 6-OHDA injection, after the
mature organization of islets has been established. Examination
of 6-OHDA-treated animals at 1.5 months of age revealed deple-
tion of sympathetic fibers in the pancreas (Figures 4A and 4B).
However, no defects were observed in islet architecture or in
glucose tolerance of sympathectomized mice (Figures 4B and
4C), indicating that sympathetic innervation is dispensable for
the maintenance of islet architecture and glucose tolerance.
Sympathetic Neurons Promote b Cell Migration through
Norepinephrine Signaling
How does sympathetic innervation influence islet formation dur-
ing development? The defects in islet architecture observed in292 Cell Reports 4, 287–301, July 25, 2013 ª2013 The AuthorsTH-Cre;TrkAf/f mice (Figures 1E and 1J) were reminiscent of
the phenotypes reported in mice where endocrine cell migration
had been disrupted (Gannon et al., 2000; Kim et al., 2005; Miet-
tinen et al., 2000). Endocrine progenitor cells migrate away from
the ducts to form mature islets. The degree of islet-duct associ-
ation is a well-established criterion of endocrine cell migratory
behavior during development (Miettinen et al., 2000). The close
association of islets with ducts is a feature commonly observed
in neonatal mice compared to functionally mature animals. We
found that 1-month-old TH-Cre;TrkAf/f mice exhibited a signifi-
cantly smaller ductal-islet distance (Figures 5A–5C), a hallmark
of reduced endocrine cell migration. We established cocultures
of sympathetic neurons with fluorescently labeled b cells iso-
lated from MIP-GFP transgenic mice and found that b cells
migrated toward explants of sympathetic ganglia when cocul-
tured in a three-dimensional Matrigel matrix, whereas b cells
cultured alone exhibited little-to-no movement in the matrix
over 7 days in culture (Figures 5D–5G, S4A, and S4B). Consistent
with migratory behavior, b cells in close proximity to sympathetic
axons frequently exhibited polarized morphologies (Figures 5H
and 5I). The b cell migratory behavior was specific to the pres-
ence of sympathetic neurons because little-to-no migration
was observed in the presence of either nonneuronal COS cells
or sensory neurons from dorsal root ganglia (DRGs) (Figure 5J).
A modified Sholl analysis (Figure 5K) to quantify the overall distri-
bution of the b cells over the culture period revealed a gradual
and directed movement of b cells toward sympathetic explants
(Figures 5L and 5M).
Sympathetic nerves innervating the pancreas release the neu-
rotransmitter norepinephrine, which activates a- and b-adren-
ergic receptors (Ahre´n, 2000). Norepinephrine has been shown
to influence the migration of peripheral cell types, including he-
matopoietic stem cells and pancreatic cancer cells (Guo et al.,
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Figure 4. Sympathetic Deinnervation in Mature Animals Does Not Affect Islet Architecture and Glucose Tolerance
(A and B) Normal islet morphology and glucose tolerance with 6-OHDA administration at a late postnatal stage (P21). P21mice were serially injected with 6-OHDA
or vehicle for 7 days and then analyzed at 1.5 months of age. TH-positive sympathetic fibers (arrows in A) are sparser in mature animals and are completely lost
with 6-OHDA administration (B).
(C) Normal glucose tolerance after sympathectomy in P21 animals (n = 6 mice for each treatment). t Test, mean ± SEM.2009; Katayama et al., 2006). In the cocultures, migration of b
cells toward sympathetic ganglia was significantly reduced by
addition of the b-adrenergic receptor antagonist propranolol
(Figures 5N, 5J and S4C). In contrast, the a-adrenergic antago-
nist phentolamine had no effect (Figures 5J and S4D). None of
the treatments changed the total number of cultured b cells (Fig-
ure S4E). In addition, the effects of sympathetic ganglia were
specific to b cells. The ganglia explants had no effect on the
migration or number of glucagon-expressing a cells in the cocul-
tures (Figures S4F and S4G). These results suggest a model in
which sympathetic neurons regulate islet formation during devel-
opment by promoting b cell migratory behavior through norad-
renergic signaling.
Developmental b-Adrenergic Signaling Regulates Islet
Architecture and Glucose Metabolism
To test the hypothesis that sympathetic neurons use noradren-
ergic neurotransmission to regulate islet structure and function,
we examined the effects of the developmental blockade of
b-adrenergic signaling on islet formation and functional matura-
tion in vivo. We administered propranolol daily to pregnant wild-
type mice from late gestation (E18) and continued injections in
the neonatal pups until P6. Propranolol injections did not affect
islet sympathetic innervation (Figures S5A and S5B) but resulted
in disruptions to neonatal islet architecture (Figures 6A–6D),
which mimicked the phenotypes observed in TH-Cre;TrkAf/f
pups. Additionally, when propranolol-injected animals were as-
sessed 6 weeks after the treatment, they exhibited glucose intol-
erance and hyperglycemia in the fed state (Figures 6E and 6F).
These results provide evidence that b-adrenergic blockade
during the developmental window of E18–P6 impairs glucose
metabolism later in life.
Next, we asked whether adrenergic stimulation during devel-
opment would be sufficient to restore islet morphologies and
functional maturity in the sympathectomized animals. Treatment
of TH-Cre;TrkAf/f mice with the b-adrenergic agonist, isoproter-
enol, from E18 to P6 resulted in a significant improvement in islet
architecture by P6, in the absence of sympathetic innervation
(Figures 6G–6L, S5C, and S5D). Because sympathetic nerves
are usually aligned with the pancreatic vasculature (Burris andHebrok, 2007; Chiu et al., 2012), these results imply that, despite
the absence of innervation in TH-Cre;TrkAf/f mice, isoproterenol
released from the islet vasculature may elicit directional migra-
tion of endocrine cells, similar to the effects of norepinephrine
released from nerve terminals. Isoproterenol treatment during
E18–P6 also improved glucose tolerance and significantly low-
ered fed blood glucose levels in TH-Cre;TrkAf/fmice, when these
metabolic parameters were examined 6 weeks later (Figures 6M
and 6N). Sympathetic innervation, islet architecture, and glucose
tolerance in control TrkAf/f animals were unaffected by the
isoproterenol administration during development (Figures 6H,
6K–6N, and S5C). Together, the loss- and gain-of function ana-
lyses indicate that islet architecture and subsequent function rely
on b-adrenergic signaling during development.
DISCUSSION
To date, all studies on sympathetic innervation of the pancreas
have focused on the modulatory functions in adult islets during
stress and exercise (Ahre´n, 2000; Woods and Porte, 1974).
Here, we provide evidence for sympathetic innervation in orga-
nizing islet architecture during normal development. Further-
more, we demonstrate that this inductive interaction at early
stages is critical for mature islet function in regulating glucose
metabolism. It is well established that sympathetic innervation
of the embryonic pancreas occurs in response to target-derived
NGF, which then supports survival of innervating neurons
(Glebova and Ginty, 2005). Our findings support the model
that, during development, sympathetic nerves, in turn, release
norepinephrine that activates b-adrenergic signaling in migrating
b cells to influence islet architecture and the acquisition of
functional maturity (Figure 7). Similar to TH-Cre;TrkAf/f animals,
b-adrenergic receptor knockout mice are glucose intolerant
and have reduced insulin secretion due to perturbations in
Glut2 levels when analyzed at adult stages (Asensio et al.,
2005; Santulli et al., 2012), although a detailed analysis of islet
development remains to be done in these mice. Together, these
findings highlight reciprocal signaling between sympathetic neu-
rons and the pancreas that results in the codevelopment of these
two physiological systems.Cell Reports 4, 287–301, July 25, 2013 ª2013 The Authors 293
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Figure 5. Sympathetic Neurons Promote b Cell Migratory Behavior through Norepinephrine Signaling
(A–C) Ductal proximity of islets in 1-month-old TH-Cre;TrkAf/f mice (n = 4 control and 3 mutant animals). Mean ± SEM; *p < 0.05, t test.
(D and E) Isolated b cells exhibit directed migration toward sympathetic (SCG) tissue explants plated in the center of a Matrigel culture dish. Scale bars, 200 mm.
(F and G) Higher-magnification images of the insets shown in (D) and (E). Scale bars, 50 mm.
(H and I) b cells align along sympathetic axons and adopt polarized morphologies when cultured with neurons (arrows in I) as compared to b cells cultured alone
(H). Scale bars, 50 mm.
(J) Percentage of b cells that have migrated toward the center of Matrigel cultures containing COS cell aggregates, DRG or SCG explants with or without
adrenergic antagonists after 7 days (n = at least 3 independent experiments). Mean ±SEM. **p < 0.01, ***p < 0.001 by one-way ANOVA and Tukey’s post hoc test.
(K–M) Sholl analysis to quantify the distribution of GFP+ b cells over 7 days in culture. The distribution of b cells cultured alone does not change significantly over
7 days (L), whereas there is a gradual shift in the distribution of b cells toward the center of the culture containing SCGs (M, arrow). Averaged profiles of four
independent experiments are plotted.
(N) b cells exhibit decreased migration toward sympathetic explants in the presence of the b-adrenergic antagonist, propranolol (see J for quantification).
Scale bar, 200 mm.
See also Figure S4.
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We found that both chemical and genetic ablation of sympa-
thetic innervation during development resulted in similar
alterations in islet shape and cellular organization. In ablating
sympathetic innervation, it would have been ideal to accomplish
pancreas-selective deletion of sympathetic fibers. However, a
potential genetic approach of pancreas-specific deletion of the
sympathetic neuron survival factor, NGF, would be expected
to perturb NGF signaling within the pancreas and thus affect
pancreas development. Moreover, surgical lesioning of sympa-
thetic projections to the pancreas cannot be accomplished in
embryonic or neonatal pups. Despite that our approaches for
deinnervation were not pancreas specific, we provided multiple
lines of evidence that indicate a direct action of sympathetic
innervation on islet architecture and function. First, in neuron-
islet cocultures, sympathetic neurons directly promote b cell
migratory behavior in a manner dependent on noradrenergic
signaling. Second, isolated islets from sympathectomized mice
show attenuated GSIS in vitro, suggesting islet-intrinsic defects
with deinnervation. Third, when injectedwith insulin, sympathec-
tomized mice responded normally with a significant reduction in
blood glucose levels, indicating normal insulin sensitivity in
peripheral tissues despite the loss of sympathetic innervation.
Fourth, in TH-Cre;TrkAf/f animals, we did not observe any
changes in the plasma levels of several intestinal hormones
and leptin that are known to influence b cell physiology. Finally,
consistent with recent findings showing that mutant mice lacking
sympathetic innervation due to genetic deletion of a key tran-
scription factor, Phox2b, have normal vascular patterning of
the heart (Nam et al., 2013), we found that vascular organization
was intact in TH-Cre;TrkAf/f islets. The preservation of the vascu-
lature further supports that the structural and functional deficits
in TH-Cre;TrkAf/f islets indeed arise from the loss of sympathetic
nerves.
We did observe a difference between the genetic and chemi-
cal approaches of sympathectomy. We found an increase in the
number of TH-positive b cells in TH-Cre;TrkAf/f mice, but not in
6-OHDA-treated animals. An upregulation in TH expression
has been reported in functionally immature or stressed islets
(Teitelman et al., 1988; Teitelman and Lee, 1987). The reasons
for TH expression in b cells and the functional consequences
of increased TH-positive cells in TH-Cre;TrkAf/f islets remain
unclear. To our knowledge, there are no reports of b cells synthe-
sizing or releasing catecholamines, raising the intriguing possi-
bility of TH functions in the pancreatic cells that are independent
of catecholamine biosynthesis. It is also important to note that
6-OHDA is unlikely to have a direct effect on islets because
rodent b cells, unlike human b cells, lack the dopamine reuptake
transporter used by 6-OHDA (Scha¨fer et al., 2013).
Our findings imply a causal relationship between the early
developmental perturbations in islet architecture and the later
functional deficits in sympathectomized animals. Both sympa-
thectomy and b-adrenergic antagonism resulted in defects in
islet architecture during development and glucose intolerance
later in life. Importantly, the restoration of islet architecture,
with b-adrenergic stimulation in sympathectomized animals,
correlated with improved function. In line with previous studies
implicating islet architecture in homogeneous and synchronous
secretory responses, our results suggest that the disorganizedislet clusters in the TH-Cre;TrkAf/fmice with the peripheral a cells
interspersed among the core b cells compromise the homotypic
intercellular interactions between b cells that is required for
optimal insulin secretion (Halban et al., 1982; Konstantinova
et al., 2007; Smolen et al., 1993). Consistent with this notion, in
deinnervated islets, we observed abnormalities in the expression
and localization of N-CAM and E-cadherin that are known medi-
ators of b cell-cell contacts and function. Similar to our observa-
tions in TH-Cre;TrkAf/f mice, N-CAM/ mutant mice show
abnormal islet architecture with intermingling of a and b cells
within the islet core as well as impaired glucose tolerance in vivo
(Esni et al., 1999; Olofsson et al., 2009). E-cadherin is necessary
for b cell clustering during pancreas development and GSIS
(Dahl et al., 1996; Jaques et al., 2008; Yamagata et al., 2002).
The relevance of intercellular contacts in normal b cell function
is underscored by animal and human studies suggesting that
perturbations in islet architecture, due to injury or disease, are
closely correlated with metabolic dysfunction (Gepts and Le-
compte, 1981; Go´mez Dumm et al., 1990; Kilimnik et al., 2011;
Tokuyama et al., 1995). In addition, it is recognized that, in the
current translational efforts for diabetes treatment, preserving
the three-dimensional arrangement of transplanted b cells could
contribute to the long-term survival and optimal function of the
transplants (Halban, 2004; Van Hoof et al., 2011). It will be of in-
terest, in future studies, to identify the signaling pathways and
transcriptional programs disrupted by the loss of cell-cell con-
tacts in the deinnervated islets. The reduced Glut2 levels and
defects in docked insulin granules in TH-Cre;TrkAf/f mice sug-
gest that the signaling pathways impinge on the glucose-sensing
and insulin-trafficking machinery.
Recent studies have reported that human and murine islets
have distinct architecture, with the different endocrine cell types
being interspersed within human islets (Brissova et al., 2005;
Cabrera et al., 2006). These findings imply that, for human islet
function, heterotypic rather than homotypic cellular interactions
within islets predominate. However, other findings suggest that,
like rodent models, human islets also require b cell-cell contacts
for efficient GSIS (Wojtusciszyn et al., 2008). In particular, at
higher glucose concentrations, homotypic contacts between
human b cells were better at facilitating insulin secretion than
heterotypic contacts (Wojtusciszyn et al., 2008), pointing to a
requirement for b cell-cell interactions in potentiating insulin
secretion, especially under highmetabolic demand. Additionally,
limited studies performed on human islets at embryonic stages
have reported that fetal islets are initially formed with a segre-
gated architecture typical of murine islets, compared to the
mixed architecture seen in adult human islets (Jeon et al.,
2009; Piper et al., 2004). These findings imply a significant plas-
ticity in islet structure that may reflect the metabolic require-
ments at a particular stage.
Recent findings have also pointed to differences in the inner-
vation patterns between mouse and human islets (Rodriguez-
Diaz et al., 2011). In human islets, sympathetic fibers do not
directly contact a and b cells as in murine islets but, instead,
innervate blood vessels within the islets. Thus, in human islets,
sympathetic modulation of hormone release is likely due to an
indirect mechanism via the release of norepinephrine into the
islet vasculature or via alterations in blood flow. However, inCell Reports 4, 287–301, July 25, 2013 ª2013 The Authors 295
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Figure 7. Developmental Interactions
between Sympathetic Neurons and Pancre-
atic Endocrine Cells
Sympathetic innervation of the embryonic
pancreas occurs in response to target-derived
NGF, which then supports survival of innervating
neurons (Glebova and Ginty, 2005). Sympathetic
nerves release norepinephrine, which acts through
b-adrenergic receptors on b cells to contribute to
endocrine cell migration and formation of discrete
islet clusters. Nerve-dependent establishment of
islet architecture is essential for intercellular con-
tacts within islets, b cell maturation (i.e., Glut2
levels), and optimal GSIS.both mice and humans, neuronal activity has similar physiolog-
ical effects on inhibiting insulin and enhancing glucagon release
in adult islets despite the differences in innervation patterns and
architecture (Ahre´n, 2000; Gilliam et al., 2007; Taborsky, 2011).
Thus, our study raises the possibility that during development,
sympathetic innervation and neuronal activity may have similar
effects in mice and humans in coordinating islet organization
and subsequent function. In support of this prediction, we note
that children with congenital insensitivity to pain with anhidrosis
(CIPA), an inherited neural disorder characterized by mutationsFigure 6. b-Adrenergic Signaling Is Necessary during Development to Regulate Islet Architect
(A and B) In vivo administration of propranolol (20 mg/kg body weight) during development (E18–P6) results in
compared to saline-injected controls.
(C and D) Quantification of islet shape and endocrine cell compartmentalization in mice injected with saline o
SEM. **p < 0.01, ***p < 0.001, t test.
(E) Glucose intolerance in 1-month-old animals injected with propranolol during development (E18.5–P6), com
for vehicle and propranolol, respectively). Mean ± SEM. *p < 0.05, t test.
(F) Developmental administration of propranolol results in elevated fed blood glucose levels in mature anima
propranolol, respectively). Mean ± SEM. **p < 0.01, t test.
(G–L) Restoration of islet morphologies in neonatal TH-Cre;TrkAf/fmice treated with a b-adrenergic receptor ag
administration (Iso., 30mg/kg bodyweight) has no effect on islet architecture in control TrkAf/fmice (G andH) b
TH-Cre;TrkAf/f mice (J) compared to saline-injected TH-Cre;TrkAf/f mice (I). (K and L) Quantification of islet
TH-Cre;TrkAf/f and control mice injected with saline or isoproterenol (n = 3mice for all treatments except for TH
*p < 0.05, **p < 0.01 one-way ANOVA with Tukey’s post hoc test. n.s., not significant.
(M) Developmental administration of isoproterenol (E18–P6) rescues the glucose intolerance in 1.5-month-old
TH-Cre;TrkAf/f mice. Isoproterenol had no effect on glucose metabolism in control TrkAf/f mice (n = 5 mice fo
vehicle-injected TH-Cre;TrkAf/f mice; and n = 7 for Iso-injected TH-Cre;TrkAf/f mice). Mean ± SEM. *p < 0.05,
Tukey’s post hoc test.
(N) Normalization of fed blood glucose levels in 1.5-month-old TH-Cre;TrkAf/f mice treated with isoprotereno
TH-Cre;TrkAf/fmice (n = 5mice for vehicle and Iso injections in TrkAf/fmice; n = 6 for vehicle-injected TH-Cre;T
mice). Mean ± SEM. *p < 0.05, ***p < 0.001, one-way ANOVA with Tukey’s post hoc test.
See also Figure S5.
Cell Reports 4, 287–3in the TrkA gene, show a deficit in glucose
responsiveness (Schreiber et al., 2005),
along with reduced peripheral innervation
(Indo et al., 1996), reminiscent of that
seen in TH-Cre;TrkAf/f mice. It is now
recognized that b cell dysfunction, inade-
quate insulin secretion, and impaired
glucose tolerance are early hallmarks of
type 2 diabetes (DeFronzo and Abdul-
Ghani, 2011; Meece, 2007). Although
autonomic neuropathy is an established
complication of diabetes (Kuehl and Ste-vens, 2012), it is important to note that autonomic dysfunction in
patients is already evident at the time of diagnosis of diabetes or
even during a clinically normal range of blood glucose levels
(Lehtinen et al., 1989; Pfeifer et al., 1984). Indeed, epidemiolog-
ical studies suggest that individuals with impaired autonomic
functions are at a greater risk of developing type 2 diabetes (Car-
nethon et al., 2003). Together with our findings, these studies
suggest that reduced or dysfunctional sympathetic innervation
of the pancreas during development may pose a risk factor for
developing diabetes later in life.ure and Glucose Metabolism
defects in islet architecture in neonatal (P6) mice,
r propranolol (n = 5 animals per genotype). Mean ±
pared to vehicle-treated controls (n = 7 and 9mice
ls at 1.5 months (n = 7 and 9 mice for vehicle and
onist, isoproterenol, from E18 to P6. Isoproterenol
ut normalizes islet structure and cytoarchitecture in
shape and endocrine cell compartmentalization in
-Cre;TrkAf/f + Iso, where n = 4 mice). Mean ± SEM.
TH-Cre;TrkAf/fmice, compared to vehicle-injected
r vehicle and Iso injections in TrkAf/f mice; n = 6 for
**p < 0.01, as determined by one-way ANOVA and
l between E18 and P6, compared to saline-treated
rkAf/fmice; and n = 7 for Iso-injected TH-Cre;TrkAf/f
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EXPERIMENTAL PROCEDURES
Mice
TrkAF592A (TrkAf/f) and TH-Cre mice were generous gifts from Dr. D. Ginty
(JHMI) and Dr. C. Gerfen (NIH), respectively. MIP-GFP mice were obtained
from Jackson Laboratory. All procedures relating to animal care and treatment
conformed to institutional and NIH guidelines.
Morphometric Analyses of Islets
Ten-micrometer-thick sections of pancreata were collected every 200 mm and
immunofluorescently labeled for insulin and glucagon. For cell counting, 10–20
representative sections of P6 pancreata were chosen and imaged on a Zeiss
AxioImager microscope using a 203 objective. The number of a and b cells
in isletswas counted and divided by the number of sections to determine endo-
crine cell numbers. Islet circularity was determined using the ImageJ software
(NIH) shape descriptors tool, calculated by the equation circularity index =
4p(area/perimeter2), with ‘‘1’’ and ‘‘0’’ denoting a perfect circle and an increas-
ingly elongated polygon, respectively. For cytoarchitecture analyses, an islet
was considered to have increased a cell core localization if more than three a
cells were localized to greater than two cell layers inside of the outer islet perim-
eter. For measurement of islet-ductal distance, 25 islets in proximity to ducts
were imaged per animal. ImageJ software was used to measure the distance
between the edge of the insulin-positive area and the closest adjacent duct.
In Vitro Islet Migration Assays
Pancreata, superior cervical ganglia (SCGs), and DRGs were harvested from
litters of 8–12 MIP-GFP mice on the day of birth. Pancreata were digested in
1 mg/ml collagenase (Type 2; Worthington Biochemical) solution in Hank’s
balanced salt solution (HBSS), washed with HBSS, and islets were picked
under an inverted fluorescent microscope. Islets were then dissociated into
single cells by gentle trituration in 4 mM EDTA in HBSS. Cell suspensions
were resuspended in DMEM with 10% fetal bovine serum and 5 U/l peni-
cillin/streptomycin (Invitrogen). To plate the cocultures, a 3 ml drop of Matrigel
(BD Biosciences) was placed in the center of a collagen-coated well in a 4-well
culture dish (Thermo Scientific). One SCG or DRG explant was embedded
in this drop. The MIP-GFP islet cell suspension was then diluted 1:1 with
Matrigel, and 10 ml of this cell suspension was plated around the central
drop containing the ganglia. Culture media containing 100 ng/ml NGF were
added, and the cultures were maintained for 7 days at 37C under 10%
CO2, with fresh media added every other day. For experiments with COS cells,
a dense suspension of COS cells wasmixed 1:1 with Matrigel and plated in the
center of the culture dish. In experiments using adrenergic antagonists, after
plating, cultures were allowed to recover overnight in culture media containing
NGF alone. The next day, fresh media containing NGF and 10 mM of pro-
pranolol (Sigma-Aldrich) or phentolamine (Sigma-Aldrich) were added. Cul-
tures were plated in duplicates or triplicates for each condition.
The cultures were imaged each day with day 1 being the day after plating,
using a Zeiss Axiovert microscope and a 2.53 objective. Four images were
taken of each well, and the images were stitched together using Adobe Photo-
shop. Sholl analyses were performed using ImageJ software and the Sholl
analysis plug-in (Ghosh Lab). To perform the analysis, a complete image of
the culture was first subjected to a threshold to only include the GFP+ cells
using the same settings for each image. The analysis plug-in was then
centered on the location of the ganglia, and the following plug-in parameters
were used: starting radius, 10 mm; ending radius, 5,000 mm; radius step size,
10 mm; radius span, 1 mm; span type, median. The Sholl analysis plots for
each well were obtained and the plots of replicate samples averaged together.
To analyze the percentage of a and b cells that migrated to the center of the
cultures at the end of the experiment, the cultures were fixed in 4% PFA and
immunostained with anti-glucagon, anti-GFP, or anti-b-III tubulin. After imag-
ing, a 1 mm diameter circle was inscribed in the middle of the image centering
on the ganglia, and the number of GFP+ or glucagon+ cells within this circle
was compared to the total number of endocrine cells using ImageJ software.
Electron Microscopy
Pancreata from 1-month-old control and mutant animals were minced and
fixed in buffer containing 3% formaldehyde, 1.5% glutaraldehyde, 5 mM298 Cell Reports 4, 287–301, July 25, 2013 ª2013 The AuthorsCaCl2, 2.5% sucrose, and 0.1 M sodium cacodylate for 1 hr at room temper-
ature. The tissue was postfixed in 1% Palade’s OsO4 for 1 hr on ice, followed
by incubation in Kellenberger’s uranyl acetate overnight at room temperature.
After dehydration through graded alcohols, the tissue was embedded in Epon,
and ultrathin (90 nm) sections were collected onto EM grids. These grids
were then imaged using an FEI Tecnai-12 TWIN transmission electron micro-
scope operating at 100 kV. Three islets were chosen at randomper animal, and
three representative images of b cells within each islet were taken. For each
image, the insulin granule density (granules/mm2 of cytoplasm) and number
of granules within 50 nm of the plasma membrane were determined using
ImageJ software.
Animal studies
Glucose Tolerance and In Vivo Analysis of GSIS and Insulin
Sensitivity
For glucose tolerance tests, 1- to 1.5-month-old mice were fasted overnight,
with a blood glucose reading the evening before the assay serving as a fed
blood glucose measurement. The next morning, mice were injected intraperi-
toneally (i.p.) with 2 g/kg glucose (Sigma-Aldrich) dissolved in water, and blood
glucose measurements were made from tail blood using a OneTouch Ultra
glucometer at the indicated times (Gu et al., 2010). For in vivo insulin secretion
assays, 1- to 2-month-old mice were fasted overnight before being injected
i.p. with 3 g/kg of glucose. Blood was collected from the tail at the times indi-
cated, spun down, and the resulting plasma fraction subjected to insulin ELISA
(Crystal Chem). For insulin sensitivity tests, 1- to 2-month-old mice were sepa-
rated into individual cages with food the evening prior to the assay. The next
morning, mice were treated with 0.75 U/kg of insulin (Novolin-R; Novo
Nordisk), and blood glucose measurements were made from tail blood at
the indicated times (Bru¨ning et al., 1997).
Analysis of GSIS and Total Islet Insulin Content in Isolated Islets
Islets were isolated as previously described by Wollheim et al. (1990). Briefly,
following euthanasia of mice, pancreata were distended using a 0.375 mg/ml
collagenase solution (Collagenase P; Roche), dissolved in HBSS (Mediatech),
and digested at 37C. The digested pancreata were then washed with HBSS
and subjected to discontinuous density gradient centrifugation using different
Ficoll densities (Mediatech). The islet layers were collected, washed with
HBSS, and islets were handpicked under an inverted microscope for subse-
quent analyses. For total insulin content assays, islets were immediately lysed
in acid ethanol solution, and the amount of insulin was determined by ELISA.
Insulin values were normalized to islet DNA content from the same lysates
using a PicoGreen kit (Invitrogen).
For insulin secretion assays in isolated islets, harvested islets were allowed
to recover overnight in RPMI-1640 media containing 10% fetal bovine serum
and 5 U/l penicillin/streptomycin. Assays were performed in Krebs-Ringer
HEPES buffer (KRBH) containing low (2.8 mM) glucose, high (25 mM) glucose,
or 30 mM potassium chloride (Sigma-Aldrich). Islets were washed in low-
glucose KRBH before being preincubated for 1 hr in low-glucose KRBH. After
preincubation, groups of ten islets were handpicked into a 24-well plate and
allowed to incubate in the conditions indicated for 1 hr. After incubation, the
supernatant fraction was removed, and the islets were lysed in acid ethanol,
followed by ELISA to determine the insulin concentration in both supernatant
and islet fractions.
Measurement of Plasma Glucagon, Ghrelin, and Nonpancreatic
Hormones
Tail vein blood was collected from 1- to 1.5-month-old mice in the evening
prior to an overnight fast (fed ad lib sample). After fasting, a second blood
sample was collected (fasted sample). Blood collected in capillary tubes
was transferred to tubes containing a protease inhibitor cocktail (Roche) on
ice. Samples were spun down, and the plasma fraction was acidified to
0.05 M HCl. Plasma samples were then subjected to a panel of ELISAs,
following the respective manufacturer’s instructions: glucagon, GLP-1, chole-
cystokinin, and secretin (Phoenix Pharmaceuticals); gastrin-1 (RayBiotech);
GIP (total, Millipore); ghrelin (active, Millipore); and leptin (Crystal Chem).
6-OHDA Treatment
Beginning on the day of birth (P0), TrkAf/fmice were injected i.p. once daily with
250 mg/kg of 6-OHDA (Sigma-Aldrich) freshly dissolved in 0.1% ascorbic acid
(Sigma-Aldrich) in 0.9% saline (Sigma-Aldrich) or with ascorbic acid-saline
solution as a control. Pups were sacrificed at P6 and pancreata processed for
TH, insulin, and glucagon immunofluorescence. For late postnatal treatments,
mice were injected beginning at P21 twice a week for 2 weeks. At 1.5 months
of age, mice were subjected to glucose tolerance measurements and sacri-
ficed to process their pancreata for immunofluorescence.
Propranolol Injections
Beginning at E18, pregnant TrkAf/f mice were injected i.p. daily with 20 mg/kg
of propranolol freshly dissolved in saline or saline alone as a control. After birth,
pups were injected using the same dosing scheme until P6 when they were
sacrificed and pancreata processed for TH, insulin, and glucagon immunoflu-
orescence. In parallel experiments, animals injected with propranolol or saline
during E18–P6 were allowed to recover for 6 weeks, and glucose tolerance
tests and blood glucose levels were assessed at 1.5 months of age.
Isoproterenol Injections
Beginning at E18, pregnant TH-Cre;TrkAf/f and control TrkAf/f mice were in-
jected daily with 30 mg/kg of isoproterenol (Sigma-Aldrich) freshly dissolved
in saline or saline alone as a control. After birth, pups were injected until P6
when they were sacrificed and pancreata processed for immunofluorescence.
Isoproterenol- and saline-injected animals were also allowed to grow to adult-
hood (1.5 months) for glucose metabolism tests.
Statistical Analyses
All graphs and statistical analyses were done using GraphPad Prism software.
Unless otherwise noted in the figure legends, statistical significance was
determined using an unpaired, two-tailed Student’s t test. See Extended
Experimental Procedures for more information.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
five figures and can be found with this article online at http://dx.doi.org/10.
1016/j.celrep.2013.06.019.
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